In fact, the report sent to the FDA on September 17, 2021, showed that 83 percent of the trial's booster recipients reported pain at the injection site.As for fatigue, 63.7 percent of booster recipients reported this side effect, while 48.4 percent reported a headache.The Centres for Disease Control and Prevention (CDC) pointed out "unsolicited adverse events".One such unsolicited adverse event was reports of lymphadenopathy, which is "plausibly related to the vaccine".READ MORE: Pfizer booster

https://www.express.co.uk/life-style/health/1517365/pfizer-booster-vaccine-lymphadenopathy-vomiting-diarrhoea

#express